Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

BACKGROUND: Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for those patients retrospectively. METHODS: A total of 122...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, Ji, Xu, Ye, Gu, Weilie, Peng, Junjie, Cai, Gang, Cai, Guoxiang, Sun, Wenjie, Shen, Weiqi, Cai, Sanjun, Zhang, Zhen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3009675/
https://ncbi.nlm.nih.gov/pubmed/21156077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-5-118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados